Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Quantification of background enhancement in breast magnetic resonance imaging.

Klifa C, Suzuki S, Aliu S, Singer L, Wilmes L, Newitt D, Joe B, Hylton N.

J Magn Reson Imaging. 2011 May;33(5):1229-34. doi: 10.1002/jmri.22545.

2.

The diagnostic sensitivity of dynamic contrast-enhanced magnetic resonance imaging and breast-specific gamma imaging in women with calcified and non-calcified DCIS.

Kim JS, Lee SM, Cha ES.

Acta Radiol. 2014 Jul;55(6):668-75. doi: 10.1177/0284185113505086. Epub 2013 Sep 16.

PMID:
24043881
3.

Evaluation of a known breast cancer using an abbreviated breast MRI protocol: Correlation of imaging characteristics and pathology with lesion detection and conspicuity.

Heacock L, Melsaether AN, Heller SL, Gao Y, Pysarenko KM, Babb JS, Kim SG, Moy L.

Eur J Radiol. 2016 Apr;85(4):815-23. doi: 10.1016/j.ejrad.2016.01.005. Epub 2016 Jan 19.

PMID:
26971429
4.

[Comparison of methods for quantifying contrast enhancement exemplified by dynamic MRI mammography].

Knopp MV, Himmelhan N, Radeleff J, Junkermann H, Hess T, Sinn HP, Brix G.

Radiologe. 2002 Apr;42(4):280-90. German.

PMID:
12063736
5.

Effects of tamoxifen and aromatase inhibitors on breast tissue enhancement in dynamic contrast-enhanced breast MR imaging: a longitudinal intraindividual cohort study.

Schrading S, Schild H, Kühr M, Kuhl C.

Radiology. 2014 Apr;271(1):45-55. doi: 10.1148/radiol.13131198. Epub 2013 Dec 10.

PMID:
24475835
6.

Background parenchymal signal enhancement ratio at preoperative MR imaging: association with subsequent local recurrence in patients with ductal carcinoma in situ after breast conservation surgery.

Kim SA, Cho N, Ryu EB, Seo M, Bae MS, Chang JM, Moon WK.

Radiology. 2014 Mar;270(3):699-707. doi: 10.1148/radiol.13130459. Epub 2013 Oct 28.

PMID:
24126372
7.

Positive enhancement integral values in dynamic contrast enhanced magnetic resonance imaging of breast carcinoma: ductal carcinoma in situ vs. invasive ductal carcinoma.

Nadrljanski M, Maksimović R, Plešinac-Karapandžić V, Nikitović M, Marković-Vasiljković B, Milošević Z.

Eur J Radiol. 2014 Aug;83(8):1363-7. doi: 10.1016/j.ejrad.2014.05.006. Epub 2014 May 16.

PMID:
24894697
8.

Comparison of contrast enhancement and diffusion-weighted magnetic resonance imaging in healthy and cancerous breast tissue.

Cho GY, Moy L, Kim SG, Klautau Leite AP, Baete SH, Babb JS, Sodickson DK, Sigmund EE.

Eur J Radiol. 2015 Oct;84(10):1888-93. doi: 10.1016/j.ejrad.2015.06.023. Epub 2015 Jul 2.

PMID:
26220915
9.

Targeting difficult accessible breast lesions: MRI-guided needle localization using a freehand technique in a 3.0 T closed bore magnet.

Meeuwis C, Peters NH, Mali WP, Gallardo AM, van Hillegersberg R, Schipper ME, van den Bosch MA.

Eur J Radiol. 2007 May;62(2):283-8. Epub 2007 Jan 10.

PMID:
17218074
10.

Preoperative clinicopathologic factors and breast magnetic resonance imaging features can predict ductal carcinoma in situ with invasive components.

Lee CW, Wu HK, Lai HW, Wu WP, Chen ST, Chen DR, Chen CJ, Kuo SJ.

Eur J Radiol. 2016 Apr;85(4):780-9. doi: 10.1016/j.ejrad.2015.12.027. Epub 2016 Jan 2.

PMID:
26971424
11.

The clinical significance of breast MRI in the management of ductal carcinoma in situ diagnosed on needle biopsy.

Miyashita M, Amano G, Ishida T, Tamaki K, Uchimura F, Ono T, Yajima M, Kuriya Y, Ohuchi N.

Jpn J Clin Oncol. 2013 Jun;43(6):654-63. doi: 10.1093/jjco/hyt055. Epub 2013 Apr 16.

PMID:
23592884
12.

[Whole-body MRI in preoperative diagnostics of breast cancer--a comparison with [corrected] staging methods according to the S 3 guidelines].

Hausmann D, Kern C, Schröder MT, Sütterlin M, Schönberg SO, Neff KW, Dinter DJ.

Rofo. 2011 Dec;183(12):1130-7. doi: 10.1055/s-0031-1281723. Epub 2011 Nov 8. German. Erratum in: Rofo. 2011 Dec;183(12):e1.

PMID:
22068844
13.

Does the degree of background enhancement in breast MRI affect the detection and staging of breast cancer?

Uematsu T, Kasami M, Watanabe J.

Eur Radiol. 2011 Nov;21(11):2261-7. doi: 10.1007/s00330-011-2175-6. Epub 2011 Jun 18.

PMID:
21688006
14.

BI-RADS-MRI terminology and evaluation of intraductal carcinoma and ductal carcinoma in situ.

Tozaki M.

Breast Cancer. 2013 Jan;20(1):13-20. doi: 10.1007/s12282-011-0312-3. Epub 2011 Nov 23.

PMID:
22109641
15.

Dynamic contrast-enhanced MRI reveals the extent and the microvascular pattern of breast ductal carcinoma in situ.

Santamaría G, Velasco M, Farrús B, Caparrós FX, Fernández PL.

Breast J. 2013 Jul-Aug;19(4):402-10. doi: 10.1111/tbj.12135. Epub 2013 Jun 12.

PMID:
23758454
16.

Suppression of unspecific enhancement on breast magnetic resonance imaging (MRI) by antiestrogen medication.

Heinig A, Lampe D, Kölbl H, Beck R, Heywang-Köbrunner SH.

Tumori. 2002 May-Jun;88(3):215-23.

PMID:
12195760
17.

Breast cancer in dense breast: detection with contrast-enhanced dynamic MR imaging.

Kawashima H, Matsui O, Suzuki M, Kadoya M, Tawara M, Nonomura A, Noguchi M, Takashima T.

J Magn Reson Imaging. 2000 Mar;11(3):233-43.

PMID:
10739554
18.

Role of ultrasonography in the detection of intraductal spread of breast cancer: correlation with pathologic findings, mammography and MR imaging.

Satake H, Shimamoto K, Sawaki A, Niimi R, Ando Y, Ishiguchi T, Ishigaki T, Yamakawa K, Nagasaka T, Funahashi H.

Eur Radiol. 2000;10(11):1726-32.

PMID:
11097398
19.

Assessment of Background Parenchymal Enhancement and Lesion Kinetics in Breast MRI of BRCA 1/2 Mutation Carriers Compared to Matched Controls Using Quantitative Kinetic Analysis.

Lewin AA, Kim SG, Babb JS, Melsaether AN, McKellop J, Moccaldi M, Klautau Leite AP, Moy L.

Acad Radiol. 2016 Mar;23(3):358-67. doi: 10.1016/j.acra.2015.11.011. Epub 2016 Jan 7.

PMID:
26774741
20.

High resolution MRI of the breast at 3 T: which BI-RADS® descriptors are most strongly associated with the diagnosis of breast cancer?

Pinker-Domenig K, Bogner W, Gruber S, Bickel H, Duffy S, Schernthaner M, Dubsky P, Pluschnig U, Rudas M, Trattnig S, Helbich TH.

Eur Radiol. 2012 Feb;22(2):322-30. doi: 10.1007/s00330-011-2256-6. Epub 2011 Sep 14.

PMID:
21913060

Supplemental Content

Support Center